FINWIRES · TerminalLIVE
FINWIRES

PHINIA Shares Slightly Down Despite Higher Q1 Adjusted Net Earnings, Net Sales

By

-- PHINIA (PHIN) shares were marginally down in Thursday trading even after the company reported higher Q1 financial results that also topped expectations.

The company reported Q1 adjusted net earnings Thursday of $1.29 per diluted share, compared with $0.94 a year earlier.

Four analysts surveyed by FactSet expected $1.13.

Net sales for the quarter ended March 31 were $878 million, compared with $796 million a year earlier.

Four analysts polled by FactSet expected $838.7 million.

The company said it continues to expect 2026 net sales in the range of $3.52 billion to $3.72 billion. Four analysts surveyed by FactSet expect $3.63 billion.

Price: $72.10, Change: $-0.05, Percent Change: -0.07%

Related Articles

Australia

Amazon's Backlog Ramp Points to Accelerating Revenue Growth, UBS Says

Amazon's (AMZN) backlog ramp, including $100 billion from Anthropic, points to accelerating revenue growth in 2026 and 2027, UBS said in a Thursday report."While there may still be some variability on the magnitude, the backlog ramp continues to point the way to accelerating revenue growth throughout 2026 and 2027, which should in turn raise investor confidence on ROIC," the note said. ROIC refers to return on invested capital.For 2026, the base case for Amazon Web Services growth is now 36%, the report said, adding that consolidated near-term revenue estimates have also moved up, driven by the e-commerce business following Q1 beat.UBS reiterated its buy rating and boosted its price target to $333 from $304.Price: $259.19, Change: $-3.85, Percent Change: -1.46%

$AMZN
Australia

Wells Fargo Adjusts Price Target on CoStar Group to $33 From $40

CoStar Group (CSGP) has an average rating of overweight and mean price target of $50.33, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $34.15, Change: $+0.01, Percent Change: +0.03%

$CSGP
Australia

Morgan Stanley Adjusts Price Target on AbbVie to $278 From $270

AbbVie (ABBV) has an average rating of overweight and mean price target of $253.15, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $213.21, Change: $+9.32, Percent Change: +4.57%

$ABBV